Dose-ranging randomized pharmacokinetic (PK) and pharmacodynamic (PD) study of vorinostat in patients with advanced solid tumors.
Tara C. Gangadhar
No relevant relationships to disclose
Jan Hendrik Beumer
No relevant relationships to disclose
Igor Espinoza-Delgado
No relevant relationships to disclose
Bean N. Anyang
No relevant relationships to disclose
Sanja Karovic
No relevant relationships to disclose
Manish Sharma
No relevant relationships to disclose
Yujia Wen
No relevant relationships to disclose
Linda A. Janisch
No relevant relationships to disclose
Hedy Lee Kindler
Consultant or Advisory Role - Merck
Research Funding - Merck
Rita Nanda
No relevant relationships to disclose
Theodore Karrison
No relevant relationships to disclose
Mark J. Ratain
No relevant relationships to disclose
Michael L. Maitland
No relevant relationships to disclose